TOWA Pharmaceutical Co (FRA:6QC) Inventories, Raw Materials & Components: €268 Mil (As of Mar. 2026)


FRA:6QC TOWA Pharmaceutical Co Ltd FRA:6QC
89 GF Score
Price €20.80
GF Value €18.10
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Inventories, Raw Materials & Components?

TOWA Pharmaceutical Co FRA:6QC +0.97% 89 Inventories, Raw Materials & Components is €268 Mil as of Mar. 2026. GuruFocus rates FRA:6QC with a GF Score™ of 89/100 and a GF Value™ of €18.10 (Modestly Overvalued). The stock has 5 warning signs investors should review.

TOWA Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €268 Mil.

TOWA Pharmaceutical Co's quarterly raw materials increased from Sep. 2025 (€274 Mil) to Dec. 2025 (€275 Mil) but then declined from Dec. 2025 (€275 Mil) to Mar. 2026 (€268 Mil).

TOWA Pharmaceutical Co's annual raw materials increased from Mar. 2024 (€234 Mil) to Mar. 2025 (€278 Mil) but then declined from Mar. 2025 (€278 Mil) to Mar. 2026 (€268 Mil).

TOWA Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Inventories, Raw Materials & Components Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 218.61 241.52 234.45 278.44 267.83

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 278.44 280.74 274.31 274.77 267.83
FRA:6QC
89GF Score
TOWA Pharmaceutical Co Ltd FRA:6QC
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €268 Mil mean?
TOWA Pharmaceutical Co (FRA:6QC) has a Inventories, Raw Materials & Components of €268 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Inventories, Raw Materials & Components too high?
TOWA Pharmaceutical Co's current Inventories, Raw Materials & Components is €268 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Inventories, Raw Materials & Components compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Inventories, Raw Materials & Components of €268 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Inventories, Raw Materials & Components is €268 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (FRA:6QC) is currently considered Modestly Overvalued. The stock's GF Value™ is €18.10, compared to a current price of €20.80 — trading 14.9% above its estimated fair value. The current Inventories, Raw Materials & Components is €268 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For TOWA Pharmaceutical Co (FRA:6QC), the current Inventories, Raw Materials & Components is €268 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (FRA:6QC) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of €20.80 is trading 14.9% above its estimated GF Value™ of €18.10. GuruFocus considers TOWA Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:6QC:

  • Inventories, Raw Materials & Components: €268 Mil
  • GF Value™: €18.10 vs. price of €20.80 (14.9% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the FRA:6QC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
89GF Score

Get the complete analysis for FRA:6QC

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.80
Price
€18.10
GF Value